A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy: The Prognostic Importance of the Area of Residual Tumor
- 1 January 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 5 (1), 49-55
- https://doi.org/10.1097/jto.0b013e3181c0a1f8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Visceral pleural invasion classification in non–small cell lung cancer: a proposal on the basis of outcome assessmentThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant TherapyLaboratory Investigation, 2003
- Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapyCancer, 2003
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessmentZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Therapy of prostatic cancer and histopathologic follow‐upThe Prostate, 1982